Attached files
| file | filename |
|---|---|
| EX-32 - EX-32 - Celldex Therapeutics, Inc. | a2241053zex-32.htm |
| EX-31.2 - EX-31.2 - Celldex Therapeutics, Inc. | a2241053zex-31_2.htm |
| EX-31.1 - EX-31.1 - Celldex Therapeutics, Inc. | a2241053zex-31_1.htm |
| EX-21.1 - EX-21.1 - Celldex Therapeutics, Inc. | a2241053zex-21_1.htm |
| EX-10.13 - EX-10.13 - Celldex Therapeutics, Inc. | a2241053zex-10_13.htm |
| EX-4.3 - EX-4.3 - Celldex Therapeutics, Inc. | a2241053zex-4_3.htm |
| 10-K - 10-K - Celldex Therapeutics, Inc. | a2241053z10-k.htm |
QuickLinks -- Click here to rapidly navigate through this document
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We hereby consent to the incorporation by reference in the Registration Statements on Form S-8 (Nos. 333-232253, 333-232255, 333-219867, 333-219869, 333-205694, 333-189336, 333-151728 and 333-117602) and on Form S-3 (Nos. 333-214882 and 333-215747) of Celldex Therapeutics, Inc. of our report dated March 26, 2020 relating to the financial statements, which appears in this Form 10-K.
/s/ PricewaterhouseCoopers LLP
Boston,
Massachusetts
March 26, 2020
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM